-+ 0.00%
-+ 0.00%
-+ 0.00%

EUROPEAN MEDICINES AGENCY CONFIRMS ACCEPTANCE OF MARKETING AUTHORIZATION APPLICATION FOR AVT05, A PROPOSED BIOSIMILAR TO SIMPONI® (GOLIMUMAB)

Reuters·11/04/2024 12:00:02

Please log in to view news